Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification

Articolo
Data di Pubblicazione:
2023
Citazione:
Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification / Moazzam, Z.; Alaimo, L.; Endo, Y.; Lima, H. A.; Shaikh, C. F.; Ratti, F.; Marques, H. P.; Cauchy, F.; Lam, V.; Poultsides, G. A.; Popescu, I.; Alexandrescu, S.; Martel, G.; Guglielmi, A.; Hugh, T.; Aldrighetti, L.; Endo, I.; Pawlik, T. M.. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - 30:2(2023), pp. 750-759. [10.1245/s10434-022-12832-2]
Abstract:
Background: The impact of early versus intermediate hepatocellular carcinoma (HCC) on short-term “optimal” outcomes remains ill-defined. This study sought to define the incidence of textbook oncologic outcomes (TOO), as well as to identify factors associated with TOO among patients with early versus intermediate HCC. Methods: Patients who underwent curative-intent liver resection for HCC (1998–2020) were identified from a multi-institutional database. Textbook oncologic outcome (TOO) was defined as negative surgical margins, no return to the operating room, no extended hospital stay, no severe complications, and no 90-day mortality or readmission. Patients were stratified as early HCC (BCLC 0 or BCLC A/Child-Pugh A) or intermediate HCC (BCLC A/Child-Pugh B or BCLC B). Multivariate logistic regression analysis was used to assess factors associated with TOO. Results: Among 1383 patients, the overall incidence of TOO was 69.0%. Patients with intermediate HCC were less likely to achieve a TOO (early [71.6 %] vs. intermediate [60.1%]; p < 0.001). On multivariate analysis, factors associated with decreased odds of a TOO were high tumor burden (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.33-1.00), high aspartate transaminase-platelet ratio index (APRI) (OR, 0.46; 95% CI, 0.30–0.70), Charlson Comorbidity Index (CCI) greater than 3 (OR, 0.67; 95% CI, 0.49–0.91), major liver resection (OR, 0.68; 95% CI, 0.52–0.90), and intermediate HCC (OR, 0.68; 95% CI, 0.50–0.93) (all p < 0.05). Notably, although high APRI, CCI greater than 3, and major liver resection contributed to lower odds of a TOO in early HCC, the only factor that adversely impacted TOO in intermediate HCC was high tumor burden. Conclusions: Patients with intermediate HCC and early HCC patients with liver dysfunction, comorbidities, or an extensive resection were less likely to achieve an “optimal” postoperative outcome.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Moazzam, Z.; Alaimo, L.; Endo, Y.; Lima, H. A.; Shaikh, C. F.; Ratti, F.; Marques, H. P.; Cauchy, F.; Lam, V.; Poultsides, G. A.; Popescu, I.; Alexandrescu, S.; Martel, G.; Guglielmi, A.; Hugh, T.; Aldrighetti, L.; Endo, I.; Pawlik, T. M.
Autori di Ateneo:
RATTI FRANCESCA
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/163579
Pubblicato in:
ANNALS OF SURGICAL ONCOLOGY
Journal
  • Dati Generali

Dati Generali

URL

https://link.springer.com/article/10.1245/s10434-022-12832-2
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0